← Leaderboards
Evaristus A Nwulia
Evon Medics, Llc
$14,602,860
Attributed
$25,704,730
Total exposure
14
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.1M · FY2010–25$20M$15M$10M$5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$48,145,920 · 15
By mechanism
U54$23,698,700 · 3
R44$13,322,137 · 5
R01$9,935,539 · 3
R43$675,000 · 2
R21$441,980 · 1
R03$72,564 · 1
Top collaborators
- Charles Chiedu Nwaokobia14 shared
- Sridevi V. Sarma12 shared
- Sumeet Seth12 shared
- Ralph Etienne-Cummings11 shared
- Kebreten F Manaye11 shared
- Nitish Vyomesh Thakor11 shared
- Youseph Yazdi11 shared
- Thomas O Obisesan9 shared
Most similar at Evon Medics, Llc
Same institution · by research overlap
- Charles Chiedu Nwaokobia$4,402,384
- Sumeet Seth$2,844,919
- Vamsi Reddy$982,458
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseInnovationSuccessEvaluationProspectiveUniversitiesFundingAlzheimer&AposProgramsPlayNeurosciencesCommunitiesBrainDevicesLeadResearch PersonnelGrantBaseSamplingSeveritiesMarketingAdultTranslationsStructure
Grant awards (57)
NeuroTech Harbor: Seedling Cohort 3$2,850,000
U54 · FY2025 · EB
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$1,280,870
R44 · FY2025 · NS
Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$1,249,244
R44 · FY2025 · AG
NeuroTech Harbor$1,000,000
U54 · FY2025 · EB
Elucidating Olfactory-Based Epigenetic Mediation of Social Contexts on Stress Response Across Life Span in Low SES Inner-City Minority Populations$636,250
R01 · FY2025 · MD · contact PI
Outreach$215,803
U54 · FY2025 · EB · contact PI
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$2,272,020
U54 · FY2024 · EB
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$1,349,130
R44 · FY2024 · NS
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$1,318,533
U54 · FY2024 · EB
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$1,254,475
U54 · FY2024 · EB
Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$1,249,244
R44 · FY2024 · AG
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,219,088
R44 · FY2024 · DA
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$1,000,000
U54 · FY2024 · EB
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$867,583
U54 · FY2024 · EB
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$743,456
U54 · FY2024 · EB
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$676,079
U54 · FY2024 · EB
Elucidating Olfactory-Based Epigenetic Mediation of Social Contexts on Stress Response Across Life Span in Low SES Inner-City Minority Populations$628,603
R01 · FY2024 · MD · contact PI
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$227,202
U54 · FY2024 · EB
Outreach$215,803
U54 · FY2024 · EB · contact PI
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$9,231,842
U54 · FY2023 · EB
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$1,318,829
R44 · FY2023 · DA
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$735,252
R01 · FY2023 · AG · contact PI
Elucidating Olfactory-Based Epigenetic Mediation of Social Contexts on Stress Response Across Life Span in Low SES Inner-City Minority Populations$654,309
R01 · FY2023 · MD · contact PI
Outreach$610,101
U54 · FY2023 · EB · contact PI
Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD)$448,887
R44 · FY2023 · AG
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$55,000
R44 · FY2023 · DA
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$1,245,116
R44 · FY2022 · AG
NeuroTech Harbor: Our nation's first equitech ecosystem for neuromedical technologies$1,000,000
U54 · FY2022 · EB
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$743,808
R01 · FY2022 · AG · contact PI
Elucidating Olfactory-Based Epigenetic Mediation of Social Contexts on Stress Response Across Life Span in Low SES Inner-City Minority Populations$651,587
R01 · FY2022 · MD · contact PI
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)$499,999
R44 · FY2022 · NS
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)$330,680
R44 · FY2022 · DA
Outreach$215,803
U54 · FY2022 · EB · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease$98,280
R44 · FY2022 · AG
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$55,795
R01 · FY2022 · AG · contact PI
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$50,000
R44 · FY2022 · AG
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD)$1,247,784
R44 · FY2021 · AG
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder$859,103
R44 · FY2021 · DA
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$748,443
R01 · FY2021 · AG · contact PI
Elucidating Olfactory-Based Epigenetic Mediation of Social Contexts on Stress Response Across Life Span in Low SES Inner-City Minority Populations$652,142
R01 · FY2021 · MD · contact PI
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$87,608
R01 · FY2021 · AG · contact PI
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$27,899
R01 · FY2021 · AG · contact PI
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder$820,883
R44 · FY2020 · DA
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$752,464
R01 · FY2020 · AG · contact PI
Elucidating Olfactory Mechanisms of PTSD Vulnerability and Trauma Resilience$189,069
R21 · FY2020 · MH · contact PI
Mechanisms of APOE-Induced Preclinical Alzheimer's Pathophysiology in Human Olfactory System$770,120
R01 · FY2019 · AG · contact PI
Elucidating Olfactory Mechanisms of PTSD Vulnerability and Trauma Resilience$252,911
R21 · FY2019 · MH · contact PI
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for relapse preventionin patients with Opioid Use (OUD)$225,000
R43 · FY2019 · DA
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$225,000
R43 · FY2019 · AG
Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD)$225,000
R43 · FY2018 · AG
Mediators of Lithium Action in Olfactory Epithelium$551,221
R01 · FY2015 · MH · contact PI
Mediators of Lithium Action in Olfactory Epithelium$553,285
R01 · FY2014 · MH · contact PI
Mediators of Lithium Action in Olfactory Epithelium$538,680
R01 · FY2013 · MH · contact PI
Mediators of Lithium Action in Olfactory Epithelium$566,041
R01 · FY2012 · MH · contact PI
Mediators of Lithium Action in Olfactory Epithelium$582,032
R01 · FY2011 · MH · contact PI
Developing Capacity for Biomedical Signal Processing and Integration of Cognitive$35,564
R03 · FY2011 · AA · contact PI
Developing Capacity for Biomedical Signal Processing and Integration of Cognitive$37,000
R03 · FY2010 · AA · contact PI